Literature DB >> 26710876

[Survival outcome comparative analysis of Liver transplantation and radical resection surgery for Klatskin tumor].

Furong Liu, Yueming Lin, Xiaoshun He, Cheng Zhang, Yi Ma, Xiaofeng Zhu, Guodong Wang, Anbin Hu.   

Abstract

OBJECTIVE: To compare the survival results of liver transplantation with radical resection for klatskin tumor based on the published literatures.
METHODS: We retrieved Medline for articles on treatment of klatskin tumor published from January 1996 to December 2014, and choose the literatures including liver transplantation and radical resection. Review Manager 5. 0 software was used to perform the Meta-analysis of the extracted data.
RESULTS: After performing meta-analysis of 11 studies including 676 patients, we found comparable patient survival rate between liver transplantation group and radical resection group (1-year RR:1. 00, 95% CI:0. 82 - 1. 23, P = 0. 97; 3-year RR:1. 15, 95% CI:0. 75 - 1. 77, P 0. 51, 5-year RR: 1. 37, 95% CI: 0. 74 - 2. 53, P = 0. 32, respectively). No statistical significance of overall survival rate were shown between this 2 groups whether in short-term or long-time, but the total survival trends show the long-time survival of LT group is better than that of RR group which has the potential longer survival time.
CONCLUSIONS: Liver transplantation was equivalent to radical resection for klatskin tumor treatment in terms of patient survival, with potential higher long-term patient survival rate and lower recurrence. especially for the patients with unrespectable KT or insufficient liver function, LT is superior for clinical outcome.

Entities:  

Mesh:

Year:  2015        PMID: 26710876

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  1 in total

Review 1.  [Precancerous and early stage cancer of the bile duct system].

Authors:  H-M Tautenhahn; S Brückner; F Rauchfuß; F Donndorf; M Ardelt; R Fahrner; A Tannapfel; U Settmacher
Journal:  Chirurg       Date:  2018-04       Impact factor: 0.955

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.